A study of more than 21,000 average risk patients at 186 sites across the U.S., led by Regenstrief Institute and Indiana University School of Medicine research scientist Thomas Imperiale, M.D., has found that the next-generation ...
Mar 13, 2024
0
1
A collaborative project to bring the promise of cell therapy to patients with a deadly form of brain cancer has shown dramatic results among the first patients to receive the novel treatment. In a paper published in the New ...
Mar 13, 2024
0
164
A blood test intended for screening for colorectal cancer in people who are of average risk and not experiencing symptoms correctly detected colorectal cancer in 83% of people confirmed to have the disease, according to a ...
Mar 13, 2024
0
2
A cancer drug duo more than doubled the survival of people battling the most common form of advanced bladder cancer, trial results show.
Mar 11, 2024
0
1
The Oregon Poison Center at Oregon Health & Science University is reporting a dramatic increase in cases of young children exposed to fentanyl. The poison center managed 16 cases of illicit fentanyl exposure in children younger ...
Mar 7, 2024
0
0
A pioneering Phase I CAR T cell therapy trial for the treatment of glioblastoma at City of Hope demonstrates promising clinical activity against incurable brain tumors, according to research published in Nature Medicine.
Mar 7, 2024
0
16
Gavinn McKinney loved Nike shoes, fireworks and sushi. He was studying Potawatomi, one of the languages of his Native American heritage. He loved holding his niece and smelling her baby smell. On his 15th birthday, the Durango, ...
Mar 7, 2024
0
0
We breathe, eat and drink tiny particles of plastic. But are these minuscule specks in the body harmless, dangerous or somewhere in between?
Mar 7, 2024
0
28
In a finding that unearths yet another way Long COVID can harm health, new research finds the condition may trigger thinking declines.
Mar 3, 2024
0
28
Cerebrospinal fluid (CSF) and other biomarkers differ for individuals with Alzheimer disease and cognitively normal controls, with the estimated times of divergence varying from 18 to six years before diagnosis, according ...
Mar 2, 2024
0
45
